Status:
UNKNOWN
Comparison of Outcome and Effectiveness Between Micropulse Diode Laser Cyclophotocoagulation and Cyclocryoablation in Treatment of Refractory Glaucoma
Lead Sponsor:
University of Health Sciences Lahore
Conditions:
Treatment of Refractory Glaucoma
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
laucoma having bad prognosis after maximally tolerated medication,glaucoma that fails after filtering operations, neovascular glaucoma, glaucoma following vitrectomy and glaucoma secondary to uveitis ...
Eligibility Criteria
Inclusion
- Positive diagnosis of refractory glaucoma
- Poor visual acuity: Hand movements or less
- Age ≥ 18 years
- Intraocular pressure ≥ 21 mmHg
- Signed informed consent
Exclusion
- Eye surgery performed over the last 3 months
- Eye inflammation
Key Trial Info
Start Date :
March 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2023
Estimated Enrollment :
47 Patients enrolled
Trial Details
Trial ID
NCT05437614
Start Date
March 1 2022
End Date
March 1 2023
Last Update
June 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Holy Family Hospital
Rawalpindi, Punjab Province, Pakistan, 46000